Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Dec, 11 2025
Feb, 2 2026
Sep, 24 2025
Jul, 21 2026
Oct, 12 2025